Insmed Incorporated
Nasdaq INSM · Bridgewater, NJ
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Immunology · Infectious disease · Musculoskeletal · Neurology · Renal & urogenital · Respiratory · Women's health
Insmed Incorporated is a clinical trial sponsor based in Bridgewater, NJ, listed as Nasdaq INSM. It has 8 active clinical trials with 2,095 planned participants, across 11 therapeutic areas. Since 2021 it has completed 25 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq INSM
Pipeline · 8 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
2 approved drug applications with a product on the market.
Questions about Insmed Incorporated
Insmed Incorporated is lead sponsor of 8 active clinical trials on ClinicalTrials.gov, with 2,095 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 25 trials and stopped 2 early.
Insmed Incorporated is based in Bridgewater, NJ and is listed as Nasdaq INSM. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Insmed Incorporated; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Insmed Incorporated.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.